Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML
- Author(s)
- Nedumannil, R; Ashby, M; Rowland, JPDr; Malherbe, JAJ; Fairbank, J; Gray, K; Loo, S; Wright, M; Reynolds, J; Hiwase, DK; Marlton, P; Fleming, SA; Bajel, A; Wei, AH;
- Journal Title
- Blood
- Publication Type
- Online publication before print
- Abstract
- The purpose of this study was to explore and determine the optimal landmark for defining complete remission after intensive induction therapy that best correlates with long-term survival outcome among patients with newly diagnosed acute myeloid leukemia (AML).
- Department(s)
- Haematology
- Publisher's Version
- https://doi.org/10.1182/blood.2025028594
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-08-26 11:57:12
Last Modified: 2025-08-26 11:57:37